Comparison of the Effects of Fibromyalgia Syndrome
Comparison of the Effects of Connective Tissue Massage and Extracorporeal Shock Wave Therapy (ESWT) in Patients With Fibromyalgia Syndrome
1 other identifier
observational
32
1 country
1
Brief Summary
Massage therapy, one of the complementary and alternative treatments, is commonly used for fibromyalgia syndrome (FMS). It may help improve pain, anxiety, depression, and sleep disorders through the complex interaction of physical and mental mechanisms. Although studies have investigated massage and extracorporeal shock wave therapy (ESWT) separately, there is currently no study directly comparing these two treatment methods. In this study, we plan to use massage therapy to reduce pain, stiffness, fatigue, and sleep difficulties in individuals with FMS. The aim is to evaluate the effects of both connective tissue massage and ESWT on fibromyalgia symptoms, with a focus on pain, fatigue, sleep disturbances, health status, and quality of life. We also aim to compare the effectiveness of these two non-pharmacological interventions in enhancing general well-being and encouraging participation in daily life. Additionally, we hope this research will contribute to clinical practice by evaluating the potential benefits of connective tissue massage, a safe and cost-effective method.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 13, 2025
CompletedFirst Posted
Study publicly available on registry
July 24, 2025
CompletedStudy Start
First participant enrolled
October 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 12, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 12, 2026
ExpectedAugust 19, 2025
August 1, 2025
6 months
July 13, 2025
August 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
3.1. Pain (Mcgill)
Higher scores indicate more severe pain. Description: Consists of 15 pain descriptors (11 sensory, 4 affective), each rated on a scale from 0 (none) to 3 (severe), plus a Visual Analog Scale (VAS) and Present Pain Intensity (PPI)
6 WEEK
Secondary Outcomes (1)
Fibromyalgia Impact Questionnaire
6 week
Study Arms (1)
CTM GROUP
ESWT GROUP
Eligibility Criteria
Patients residing in Istanbul who applied to our center, both employed and unemployed, were included
You may qualify if:
- Clinical diagnosis of fibromyalgia syndrome
- Aged between 18 and 60 years
- Female gender
- Symptoms present for at least 6 months
- Willing to participate in the study
- Literate
You may not qualify if:
- History of rheumatologic, neurologic, psychiatric, or systemic disease
- Pregnancy or lactation
- Prior treatment with massage or ESWT
- History of acute infection, trauma, or surgery
- History of cancer
- Use of painkillers or antidepressants
- Any medical condition that prevents participation in physical activity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istanbul Gerontechnology Research Center
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 13, 2025
First Posted
July 24, 2025
Study Start
October 20, 2025
Primary Completion
April 12, 2026
Study Completion (Estimated)
June 12, 2026
Last Updated
August 19, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share